Biotechnology San Diego, USA-based biotech DelMar Pharmaceuticals’ shot up 20% pre-market today, as it revealed the signing of a definitive merger agreement with Adgero Biopharmaceuticals, a privately held biopharmaceutical company focused on the development of its late-stage photodynamic therapy platform for the treatment of serious cutaneous oncology indications. 10 June 2020